Package 0078-0592-87

{"route": ["ORAL"], "spl_id": "fe0fef5b-4f09-4f67-946f-67e84d10e102", "openfda": {"unii": ["5JHU0N1R6K"], "rxcui": ["746606", "746609", "997653", "1002300", "2002717", "2002719"], "spl_set_id": ["6093952a-5248-45cb-ad17-33716a411146"], "manufacturer_name": ["Novartis Pharmaceuticals Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "28 CAPSULE in 1 BLISTER PACK (0078-0592-51)", "package_ndc": "0078-0592-51", "marketing_start_date": "20071029"}, {"sample": false, "description": "4 BLISTER PACK in 1 CARTON (0078-0592-87)  / 28 CAPSULE in 1 BLISTER PACK", "package_ndc": "0078-0592-87", "marketing_start_date": "20071029"}], "brand_name": "Tasigna", "product_id": "0078-0592_fe0fef5b-4f09-4f67-946f-67e84d10e102", "dosage_form": "CAPSULE", "pharm_class": ["Bcr-Abl Tyrosine Kinase Inhibitors [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Kinase Inhibitor [EPC]", "P-Glycoprotein Inhibitors [MoA]", "UGT1A1 Inhibitors [MoA]"], "product_ndc": "0078-0592", "generic_name": "nilotinib", "labeler_name": "Novartis Pharmaceuticals Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tasigna", "active_ingredients": [{"name": "NILOTINIB HYDROCHLORIDE MONOHYDRATE", "strength": "150 mg/1"}], "application_number": "NDA022068", "marketing_category": "NDA", "marketing_start_date": "20071029", "listing_expiration_date": "20261231"}